CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma

Cancer Science

Volumn 104, Issue 9, 2013, Pages 1237-1244

  Ohnishi, Koji ^a   Komohara, Yoshihiro ^a   Saito, Yoichi ^a   Miyamoto, Yuji ^a   Watanabe, Masayuki ^a   Baba, Hideo ^a   Takeya, Motohiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SIALOADHESIN;

ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CD8+ T LYMPHOCYTE; COLORECTAL CARCINOMA; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE; MACROPHAGE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTERFERONS; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; LYMPHATIC METASTASIS; MACROPHAGES; MALE; MIDDLE AGED; PROGNOSIS; SIALIC ACID BINDING IG-LIKE LECTIN 1; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84883465032     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12212     Document Type: Article

References (35)

1. Lores B, García-Estevez JM, Arias C. Lymph nodes and human tumors (review). Int J Mol Med 1998; 1: 729-33.
2. Hickok DF, Miller L, Harris L. Regional hyperplastic lymph nodes in breast cancer: the role of lymphocytes and nodal macrophages. An immunological study with a five-year follow-up. Surgery 1977; 82: 710-15.
3. Gray EE, Cyster JG. Lymph node macrophages. J Innate Immun 2012; 4: 424-36.
4. Martens JH, Kzhyshkowska J, Falkowski-Hansen M et al. Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 2006; 208: 574-89.
5. Martinez-Pomares L, Gordon S. CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol 2012; 33: 66-70.
6. Nath D, Hartnell A, Happerfield L et al. Macrophage-tumour cell interactions: identification of MUC1 on breast cancer cells as a potential counter-receptor for the macrophage-restricted receptor, sialoadhesin. Immunology 1999; 98: 213-19.
7. van den Berg TK, Nath D, Ziltener HJ et al. Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1). J Immunol 2001; 166: 3637-40.
8. Klaas M, Crocker PR. Sialoadhesin in recognition of self and non-self. Semin Immunopathol 2012; 34: 353-64.
9. Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 2001; 97: 288-96.
10. Biesen R, Demir C, Barkhudarova F et al. Sialic acid-binding Ig-like lectin 1 expression in inflammatory and resident monocytes is a potential biomarker for monitoring disease activity and success of therapy in systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1136-45.
11. York MR, Nagai T, Mangini AJ, Lemaire R, van Seventer JM, Lafyatis R. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists. Arthritis Rheum 2007; 56: 1010-20.
12. Ikezumi Y, Suzuki T, Hayafuji S et al. The sialoadhesin (CD169) expressing a macrophage subset in human proliferative glomerulonephritis. Nephrol Dial Transplant 2005; 20: 2704-13.
13. Nagase R, Kajitani N, Shikata K et al. Phenotypic change of macrophages in the progression of diabetic nephropathy; sialoadhesin-positive activated macrophages are increased in diabetic kidney. Clin Exp Nephrol 2012; 16: 739-48.
14. Xiong YS, Zhou YH, Rong GH et al. Siglec-1 on monocytes is a potential risk marker for monitoring disease severity in coronary artery disease. Clin Biochem 2009; 42: 1057-63.
15. Xiong YS, Wu AL, Lin QS et al. Contribution of monocytes Siglec-1 in stimulating T cells proliferation and activation in atherosclerosis. Atherosclerosis 2012; 224: 58-65.
16. Ashokkumar C, Gabriellan A, Ningappa M, Mazariegos G, Sun Q, Sindhi R. Increased monocyte expression of sialoadhesin during acute cellular rejection and other enteritides after intestine transplantation in children. Transplantation 2012; 93: 561-4.
17. Wu C, Rauch U, Korpos E et al. Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J Immunol 2009; 182: 6508-16.
18. Komohara Y, Hirahara J, Horikawa T et al. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype. J Histochem Cytochem 2006; 54: 763-71.
19. Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008; 216: 15-24.
20. Ohnishi K, Komohara Y, Sakashita N, Iyama K, Murayama T, Takeya M. Macrophages in Langerhans cell histiocytosis are differentiated toward M2 phenotype: their possible involvement in pathological processes. Pathol Int 2010; 60: 27-34.
21. Compton CC, Fielding LP, Burgart LJ et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 979-94.
22. Heusinkveld M, van der Burg SH. Identification and manipulation of tumor associated macrophages in human cancers. J Transl Med 2011; 9: 216.
23. Naito Y, Saito K, Shiiba K et al. CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 1998; 58: 3491-4.
24. Guidoboni M, Gafà R, Viel A et al. Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. Am J Pathol 2001; 159: 297-304.
25. Galon J, Costes A, Sanchez-Cabo F et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-4.
26. Pagès F, Kirilovsky A, Mlecnik B et al. In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer. J Clin Oncol 2009; 27: 5944-51.
27. Kondratiev S, Sabo E, Yakirevich E, Lavie O, Resnick MB. Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 2004; 10: 4450-6.
28. Sharma P, Shen Y, Wen S et al. CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci U S A 2007; 104: 3967-72.
29. Lee HE, Chae SW, Lee YJ et al. Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer 2008; 99: 1704-11.
30. Baker K, Lachapelle J, Zlobec I, Bismar TA, Terracciano L, Foulkes WD. Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade. Histopathology 2011; 58: 1107-16.
31. Martinet L, Garrido I, Filleron T et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71: 5678-87.
32. Liu Y, Komohara Y, Domenick N et al. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer. Cancer Immunol Immunother 2012; 61: 789-801.
33. Erdag G, Schaefer JT, Smolkin ME et al. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res 2012; 72: 1070-80.
34. Asano K, Nabeyama A, Miyake Y et al. CD169-positive macrophages dominate antitumor immunity by crosspresenting dead cell-associated antigens. Immunity 2011; 34: 85-95.
35. Barral P, Polzella P, Bruckbauer A et al. CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol 2010; 11: 303-12.